Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Buprenorph hydrochloride/naloxone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Suboxone 8mg/2mg sublingual tablets
0410030B0BBAAAA
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 384 |
|
Suboxone 2mg/500microgram sublingual tablets
0410030B0BBABAB
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 349 |
|
Buprenorphine 2mg / Naloxone 500microgram SL tab sugar free
0410030B0AAABAB
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 232 |
|
Buprenorphine 8mg / Naloxone 2mg sublingual tab sugar free
0410030B0AAAAAA
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 195 |
|
Suboxone 2mg/500microgram sublingual films
0410030B0BBADAD
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 8 |
|
Suboxone 8mg/2mg sublingual films
0410030B0BBAEAE
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 6 |
|
Zubsolv 1.4mg/0.36mg sublingual tablets
0410030B0BCAAAG
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 3 |
|
Buprenorphine 16mg / Naloxone 4mg sublingual tab sugar free
0410030B0AAACAC
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 2 |
|
Buprenorphine 2mg / Naloxone 500microgram SL films SF
0410030B0AAADAD
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 2 |
|
Buprenorphine 5.7mg / Naloxone 1.4mg SL tab sugar free
0410030B0AAAIAI
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 1 |
|
Buprenorphine 1.4mg / Naloxone 360microgram SL tab SF
0410030B0AAAGAG
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 11.4mg / Naloxone 2.9mg SL tab sugar free
0410030B0AAAJAJ
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 2.9mg / Naloxone 710microgram SL tab SF
0410030B0AAAHAH
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 8.6mg / Naloxone 2.1mg SL tab sugar free
0410030B0AAAFAF
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 8mg / Naloxone 2mg sublingual films sugar free
0410030B0AAAEAE
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Suboxone 16mg/4mg sublingual tablets
0410030B0BBACAC
|
Suboxone | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 11.4mg/2.9mg sublingual tablets
0410030B0BCADAJ
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 2.9mg/0.71mg sublingual tablets
0410030B0BCABAH
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 5.7mg/1.4mg sublingual tablets
0410030B0BCACAI
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Zubsolv 8.6mg/2.1mg sublingual tablets
0410030B0BCABAF
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.